Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

v3.24.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Stock-Based Compensation [Abstract]  
Schedule of Stock-Based Compensation Expense Recognized The Company recognized total expenses for stock-based compensation during the year ended December 31, 2023 and the year ended December 31, 2022, which are included in the accompanying statements of operations, as follows (in thousands):
    Year Ended
December 31,
    Year Ended
December 31,
 
    2023     2022  
             
Research and development expenses   $ 178     $ 508  
Selling, general and administrative expenses     536       1,897  
Total stock-based compensation   $ 714     $ 2,405  

 

Schedule of Restricted Stock Activity A summary of the Company’s restricted stock activity during the year ended December 31, 2023 is as follows:
    Number of
Shares
    Weighted Average
Grant-Date
Fair Value
 
Unvested at December 31, 2022     10,483     $ 138  
Granted     1,992,345     $ 0.25  
Vested     (305,924 )   $ 2.34  
Unvested at December 31, 2023     1,696,904     $ 0.38  
Schedule of Activity Under the Plans The following was used in determining the fair value of stock options granted during the year ended December 31, 2023 and December 31, 2022.
    Year Ended
December 31,
    Year Ended
December 31,
 
    2023     2022  
Dividend yield     0%     0%
Expected price volatility     83.6% - 107.3%       88.8% - 91.7%  
Risk free interest rate     4.3% - 4.8%       3.25% - 3.96%  
Expected term     5.8 years       5.0 - 7.0 years  
Schedule of Activity Under the Plans A summary of activity under the 2016 and 2020 Plans for the year ended December 31, 2023 is as follows:
    Shares
Underlying
Options
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual
Term
(Years)
    Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2022     159,295     $ 158.40       6.50     $ 26,188  
Granted     225,000       0.23       9.87          
Forfeited     (1,516 )     196.86       -          
Outstanding at December 31, 2023     382,779       65.04       8.10       -  
Exercisable at December 31, 2023     156,522       155.36       5.59       -